Monoclonal Anti-alpha-synuclein Antibodies For Preventing Tau Aggregation

Abstract

The invention relates to a novel use of monoclonal anti-alpha-synuclein antibodies. The antibodies can be used to prevent tau aggregation and thereby treating tauopathies such as Alzheimer's disease.


Claims
Family Member PDF
Family Member Preview
These are the images from a related family member, as the full document isn't yet available to us from the patent office.
Document History
  • Publication: Jun 28, 2018
  • Application: Dec 21, 2017
    WO EP 2017083994 W
  • Priority: Jan 5, 2017
    DK DK PA201700016 A
  • Priority: Dec 22, 2016
    DK DK PA201600782 A

Download Citation


Sign in to the Lens

Feedback